EP0779813A4 - Phosphonates and parathyroid hormone for osteoporosis - Google Patents

Phosphonates and parathyroid hormone for osteoporosis

Info

Publication number
EP0779813A4
EP0779813A4 EP95933745A EP95933745A EP0779813A4 EP 0779813 A4 EP0779813 A4 EP 0779813A4 EP 95933745 A EP95933745 A EP 95933745A EP 95933745 A EP95933745 A EP 95933745A EP 0779813 A4 EP0779813 A4 EP 0779813A4
Authority
EP
European Patent Office
Prior art keywords
phosphonates
osteoporosis
parathyroid hormone
parathyroid
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95933745A
Other languages
German (de)
French (fr)
Other versions
EP0779813A1 (en
Inventor
Ann Dunbar Geddes
John Althorp Bevan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP0779813A1 publication Critical patent/EP0779813A1/en
Publication of EP0779813A4 publication Critical patent/EP0779813A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP95933745A 1994-09-09 1995-09-06 Phosphonates and parathyroid hormone for osteoporosis Withdrawn EP0779813A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30398194A 1994-09-09 1994-09-09
US303981 1994-09-09
PCT/US1995/011336 WO1996007418A1 (en) 1994-09-09 1995-09-06 Phosphonates and parathyroid hormone for osteoporosis

Publications (2)

Publication Number Publication Date
EP0779813A1 EP0779813A1 (en) 1997-06-25
EP0779813A4 true EP0779813A4 (en) 1998-05-06

Family

ID=23174525

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95933745A Withdrawn EP0779813A4 (en) 1994-09-09 1995-09-06 Phosphonates and parathyroid hormone for osteoporosis

Country Status (9)

Country Link
EP (1) EP0779813A4 (en)
JP (1) JPH10505091A (en)
KR (1) KR970705399A (en)
CN (1) CN1157566A (en)
AU (1) AU686019B2 (en)
CA (1) CA2199251A1 (en)
IL (1) IL115223A0 (en)
PE (1) PE48597A1 (en)
WO (1) WO1996007418A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
EP1296689B3 (en) 2000-06-20 2013-02-13 Novartis AG Method of administering bisphosphonates
US20040014726A1 (en) * 2000-10-27 2004-01-22 Thua Osterman Method for the preparation of a pharmaceutical composition, and its use
WO2007059470A2 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP2013512688A (en) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ Methods of using black bear parathyroid hormone and black bear parathyroid hormone

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0514720A2 (en) * 1991-05-03 1992-11-25 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
WO1993011786A1 (en) * 1991-12-17 1993-06-24 Procter & Gamble Pharmaceuticals, Inc. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0514720A2 (en) * 1991-05-03 1992-11-25 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
WO1993011786A1 (en) * 1991-12-17 1993-06-24 Procter & Gamble Pharmaceuticals, Inc. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9607418A1 *

Also Published As

Publication number Publication date
KR970705399A (en) 1997-10-09
JPH10505091A (en) 1998-05-19
PE48597A1 (en) 1997-12-11
EP0779813A1 (en) 1997-06-25
IL115223A0 (en) 1995-12-31
WO1996007418A1 (en) 1996-03-14
CA2199251A1 (en) 1996-03-14
AU3627795A (en) 1996-03-27
CN1157566A (en) 1997-08-20
AU686019B2 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
LT99010A (en) Parathyroid hormone analogues for the treatment of osteoporosis
IL112455A0 (en) Combination treatment for osteoporosis
IL132901A0 (en) Peptide parathyroid hormone analogs
ZA929758B (en) Methods for the treatment of osteoporosis using biphosphonates and parathyroid hormone
HUP9901718A3 (en) Analogs of parathyroid hormone
AP9700934A0 (en) Combination therapy for osteoporosis
IL130794A0 (en) Analogs of parathyroid hormone
IL115529A0 (en) Benzo-fused compounds
IL127781A0 (en) Steroid bisphosphonates
GB9414909D0 (en) Osteoporosis apparatus
EP0656784A4 (en) Parathyroid hormone fragments and analogs.
EP0779813A4 (en) Phosphonates and parathyroid hormone for osteoporosis
GB9518611D0 (en) Anti-apoptotic factors
EP0779812A4 (en) Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
GB2309083B (en) Osteoporosis apparatus
GB9422192D0 (en) Apparatus for forming malleable material
ZA961860B (en) Method for the treatment of osteoporosis using estrogen compounds and parathyroid hormone
GB9615350D0 (en) Hormone replacement therapy
GB9513495D0 (en) Material remover
TW347778U (en) Auxiliary material-receiving apparatus
HU0600009D0 (en) Analogs of parathyroid hormone
GB9406641D0 (en) Image intensifier
ZA961859B (en) Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
GB9410970D0 (en) Bit-focussed multiplier
GB9425901D0 (en) Server for kelver

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970403

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

RHK1 Main classification (correction)

Ipc: A61K 38/29

A4 Supplementary search report drawn up and despatched

Effective date: 19980319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19991020

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000301